CN1164191C - Polypeptide chewing gum - Google Patents
Polypeptide chewing gum Download PDFInfo
- Publication number
- CN1164191C CN1164191C CNB011152400A CN01115240A CN1164191C CN 1164191 C CN1164191 C CN 1164191C CN B011152400 A CNB011152400 A CN B011152400A CN 01115240 A CN01115240 A CN 01115240A CN 1164191 C CN1164191 C CN 1164191C
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- peptide
- chewing gum
- chewing
- casein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Confectionery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to polypeptide chewing gum which is prepared by that at least two kinds of casein peptide is added to chewing gum when ingredients are prepared in the publicly known chewing gum preparation procedure; casein composite polypeptide is added to chewing gum raw materials so that the chewing gum has a fragrant mouth feel and a fashionable characteristic, and has the function of repairing and regenerating dental caries.
Description
The present invention relates to a kind of chewing gum that contains the casein polypeptide.
Polypeptide is a kind of bioactivator, can directly be absorbed by human body, and different peptides has different physiological functions.The peptide that studies have shown that in the cow's milk peptide has: the blood pressure lowering peptide that suppresses angiotensin I invertase activity; The morphine-like peptide that tranquilizing soporific is arranged; The immunomodulatory peptides that can suppress bacterium and virus infections; Draw hematoblastic cohesion and fibrinogen and be attached to antithrombotic peptide on the blood platelet that ADP activates; Promote the CPP that calcium, iron, zinc absorb; Promote the peptide that DNA is synthetic and cell is grown; Antibiotic anticancer anti-mutagenized polypeptide etc.
At present, external active casein polypeptide played a part with different effects in fields such as health products, medicine, beverage additive, family's non-staple food special.Casein is degraded to the focus that active peptides is present dairy products research and development with various enzymes.Abroad, the part casein peptide is commercialization and very fast-selling, aspect this biotechnology, at present Japan and Northern Europe are walked in prostatitis, secondly countries such as the U.S., Australia, Germany, France, Korea S all carry out positive research, and in the end of the year 1989, Japan has at first realized CPP suitability for industrialized production, release the functional food that contains active peptides simultaneously, Denmark also realized commercialization in 1991.Functional food comes from Japan, and is also in vogue in Japan at present.Japan has been applied to polypeptide the beverage that children's curry meal, liquid nutritional food, candy, strong bone are replenished the calcium, allergic reaction dairy produce for baby " MA-1 ", " MA-2 " etc.Taiwan also has the CPP beverage that all contains of commodity " the good iron of calcium " by name to go on the market, and the utmost point gets consumer reception.France successfully is that the antithrombotic peptide of raw material behind enzymolysis made the product that prevents and treat thrombotic disease with CMP in the nineties.
The chemical elementary cell of active casein polypeptide is an amino acid, constitutes the different peptides with given efficacy because of amino acid whose composition is different.Product appearance is white or light yellow powdery, has unique bitter taste when debitterize is not distinguished the flavor of, and is soluble in water, because its very high nutritive value and specific physiological function are widely used in fields such as grocery trade, health products, medicine, feed, family's non-staple food.In recent years, studies have shown that both at home and abroad that small-molecular peptides has higher biologically active and nutritive value than the free amino acid of equivalent, and polypeptide is almost all directly absorbed in human body.
The existing consumer goods of chewing gum as a kind of popular, fashion, its frequency of utilization, amount are not less than toothpaste, even exceed toothpaste in some colonies; And in the oral cavity holdup time long, bring into play the optimum carrier of anti-carious tooth class material just.And composite casein polypeptide, in recent years, discovery of external medical institutions and confirmation phosphopeptide wherein have good effect to the reparative regeneration of carious tooth, and state is existing to be applied in it in toothpaste.
The objective of the invention is composite casein polypeptide to be added in the chewing-gum material, make mouthful the fragrant fashion characteristic but also have the polypeptide chewing gum of reparative regeneration carious tooth effect of not only having had in order to provide a kind of.
Purpose of the present invention can realize by following measure:
A kind of polypeptide chewing gum is in known chewing gum preparation section, adds composite casein polypeptide in chewing-gum material, and wherein composite casein polypeptide is the 0.1-2% of chewing-gum material weight.
The present invention has following advantage compared to existing technology:
1, the present invention is compounded into the composite casein polypeptide of tool bioactivator in the chewing-gum material, makes not only to have a fashion characteristic but also with health role; Casein phosphopeptide wherein also can be repaired carious tooth simultaneously, and carious tooth is had good palingenesis, because chewing gum time of staying in the oral cavity is long, thereby can bring into play the effect of the anti-carious tooth of casein phosphopeptide well.
2, after phosphopeptide of the present invention enters alimentary canal from the oral cavity, can promote the absorption of calcium after the absorption, help skeleton health, prevent calcium deficiency.
3, the present invention can play human body and regulate immunity of organisms, delay senility, anti-mutagenesis, prevent effect such as osteoporosis.
The present invention also will be described in further detail in conjunction with the embodiments:
Embodiment one:
A kind of polypeptide chewing gum is in the preparation section of known chewing gum, adds casein phosphopeptide, calcium peptide when it is prepared burden, and wherein casein phosphopeptide is 0.2% of a chewing-gum material weight, and CCP is 0.1% of a chewing-gum material weight; Casein phosphopeptide, calcium peptide and chewing-gum material be mixed get final product.
Embodiment two:
A kind of polypeptide chewing gum is in known chewing gum preparation section, when batching, add casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, wherein casein phosphopeptide is 0.5% of a chewing-gum material weight, CCP is 0.2% of a chewing-gum material weight, blood pressure lowering peptide is 1% of a chewing-gum material weight, and the antithrombotic peptide is 0.1% of a chewing-gum material weight: casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide and chewing-gum material are mixed to get final product.
Embodiment three:
A kind of polypeptide chewing gum is in known chewing gum preparation section, when batching, add casein phosphopeptide, the calcium peptide, blood pressure lowering peptide, the antithrombotic peptide, the morphine peptide, immunomodulatory peptides, anti-mutagenized polypeptide, wherein casein phosphopeptide is 1% of a chewing-gum material weight, CCP is 0.1% of a chewing-gum material weight, blood pressure lowering peptide is 0.1% of a chewing-gum material weight, the antithrombotic peptide is 0.3% of a chewing-gum material weight, the morphine peptide is 0.3% of a chewing-gum material weight, immunomodulatory peptides is 0.1% of a chewing-gum material weight, and anti-mutagenized polypeptide is 0.1% of a chewing-gum material weight; Casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides, anti-mutagenized polypeptide and chewing-gum material be mixed get final product.
Claims (2)
1, a kind of polypeptide chewing gum is characterized in that it being by in known chewing gum preparation section, adds composite casein polypeptide and make when batching, and wherein composite casein polypeptide is the 0.1-2% of chewing-gum material weight.
2, polypeptide chewing gum as claimed in claim 1 is characterized in that described composite casein polypeptide is selected from least two kinds of peptides in casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides and the anti-mutagenized polypeptide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011152400A CN1164191C (en) | 2001-04-27 | 2001-04-27 | Polypeptide chewing gum |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011152400A CN1164191C (en) | 2001-04-27 | 2001-04-27 | Polypeptide chewing gum |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1383730A CN1383730A (en) | 2002-12-11 |
CN1164191C true CN1164191C (en) | 2004-09-01 |
Family
ID=4661817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011152400A Expired - Fee Related CN1164191C (en) | 2001-04-27 | 2001-04-27 | Polypeptide chewing gum |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1164191C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102783550A (en) * | 2012-08-31 | 2012-11-21 | 中国食品工业(集团)公司 | Preparation process of preserved fruit of casein complex polypeptide sour pear and product prepared by using preparation process |
CN104543275B (en) * | 2015-02-03 | 2017-12-12 | 韩山师范学院 | One kind is rich in small molecular protein peptide gel candy and preparation method thereof |
-
2001
- 2001-04-27 CN CNB011152400A patent/CN1164191C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1383730A (en) | 2002-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2216250C (en) | Casein phosphopeptide, casein containing same and process for the preparation thereof | |
AU2004261522B2 (en) | Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food | |
CN101098675B (en) | Stabilized calcium phosphate complexes | |
CA2565889C (en) | Oral flora-improving agent, antibacterial agent and growth promoter | |
CA2371696A1 (en) | Composition for an infant formula having a low threonine content | |
CN101330943A (en) | Surface active calcium phosphates | |
JP5467876B2 (en) | Method for producing chewable tablets | |
CN103889398B (en) | Oral cavity composition | |
CN1164191C (en) | Polypeptide chewing gum | |
JP2004238320A (en) | Bone absorption inhibitor | |
JPWO2009057287A1 (en) | Food material for inhibiting osteoclast formation | |
CN1173633C (en) | Polypeptide biscuit | |
CN1173648C (en) | Composite casein polypeptide beverage | |
CN1173632C (en) | Nutritious health polypeptide flour | |
AU2007259959B2 (en) | Agent for maintaining the hardness of tooth structure | |
JPS60156620A (en) | Dental caries controller | |
CN1199573C (en) | Polypeptide fortified milk | |
KR20100105561A (en) | Food material for inhibiting bone resorption | |
CN1383737A (en) | Polypeptide bean curd | |
CN1094309A (en) | Mineral absorption factor peptide calcium and preparation method of preparation thereof | |
CN101524109B (en) | Nutritional nondairy creamer chewing gum | |
CN101023771A (en) | Mustard-pumpkin sweet | |
JP2008290975A (en) | Skin whitening agent | |
RU2054933C1 (en) | Preparation for prophylaxis and treatment of gastroenteric disease in newborn calves | |
CN1068197C (en) | Use of Lumeikesi Hybrid acid film for preparation of cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040901 Termination date: 20100427 |